Gene G. Hunder
#116,561
Most Influential Person Now
Gene G. Hunder's AcademicInfluence.com Rankings
Gene G. Hunderphilosophy Degrees
Philosophy
#5088
World Rank
#7810
Historical Rank
Logic
#2421
World Rank
#3411
Historical Rank
Download Badge
Philosophy
Why Is Gene G. Hunder Influential?
(Suggest an Edit or Addition)Gene G. Hunder's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. (2008) (5019)
- Nomenclature of systemic vasculitides. Proposal of an international consensus conference. (1994) (3126)
- Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. (1998) (2756)
- The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. (2010) (2232)
- The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). (2010) (1997)
- The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. (2010) (1952)
- The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. (2010) (1862)
- The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. (2010) (969)
- The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. (2010) (796)
- Takayasu Arteritis: A STUDY OF 32 NORTH AMERICAN PATIENTS (1985) (648)
- The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. (2010) (621)
- The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. (2010) (569)
- Polymyalgia rheumatica and giant cell arteritis. (1978) (567)
- Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. (1982) (567)
- Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. (2003) (543)
- Increased Incidence of Aortic Aneurysm and Dissection in Giant Cell (Temporal) Arteritis: A Population-Based Study (1995) (539)
- Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. (1978) (519)
- Primary central nervous system vasculitis: analysis of 101 patients (2007) (513)
- A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. (2002) (503)
- Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. (2003) (501)
- Large artery involvement in giant cell (temporal) arteritis. (1975) (486)
- Steroid-responsive encephalopathy associated with autoimmune thyroiditis. (2006) (456)
- The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. (2011) (441)
- Tissue Cytokine Patterns in Patients with Polymyalgia Rheumatica and Giant Cell Arteritis (1994) (371)
- How Does Previous Corticosteroid Treatment Affect the Biopsy Findings in Giant Cell (Temporal) Arteritis? (1994) (353)
- Visual prognosis in giant cell arteritis. (1993) (350)
- Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. (1993) (350)
- Polymyalgia rheumatica and giant-cell arteritis. (1995) (335)
- Neurologic disease in biopsy‐proven giant cell (temporal) arteritis (1988) (335)
- The Incidence of Giant Cell Arteritis in Olmsted County, Minnesota: Apparent Fluctuations in a Cyclic Pattern (1995) (326)
- Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. (1993) (316)
- Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial. (2006) (297)
- Polymyalgia rheumatica and giant-cell arteritis (2008) (295)
- Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study. (1975) (285)
- Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity. (2000) (283)
- Skip lesions in temporal arteritis. (1976) (279)
- Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985. (1988) (257)
- THE THERAPEUTIC IMPACT OF TEMPORAL ARTERY BIOPSY (1983) (255)
- Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. (2004) (255)
- The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods. (2010) (250)
- Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis (2012) (246)
- The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. (2010) (246)
- Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. (2012) (238)
- Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica. (1997) (229)
- Giant cell arteritis with low erythrocyte sedimentation rate: Frequency of occurrence in a population‐based study (2001) (214)
- Aortic Aneurysm and Dissection in Patients With Biopsy-Proven Giant Cell Arteritis From Northwestern Spain: A Population-Based Study (2004) (211)
- Adult primary central nervous system vasculitis (2012) (209)
- Transient regional osteoporosis. A study of 56 cases and review of the literature. (1987) (207)
- Thoracic aortic aneurysm and rupture in giant cell arteritis. A descriptive study of 41 cases. (1994) (205)
- The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule. (1992) (200)
- Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991. (1995) (197)
- Hypersensitivity vasculitis and Henoch-Schönlein purpura: a comparison between the 2 disorders. (1992) (196)
- Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. (2003) (194)
- HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis. (1994) (185)
- Peripheral neuropathy associated with sicca complex (1997) (185)
- Prognostic markers of radiographic progression in early rheumatoid arthritis. (2004) (181)
- Clinical features of polymyalgia rheumatica and giant cell arteritis (2012) (179)
- Production, degradation, and circulating levels of 1,25-dihydroxyvitamin D in health and in chronic glucocorticoid excess. (1980) (174)
- Musculoskeletal manifestations of bacterial endocarditis. (1977) (154)
- Giant cell arteritis (temporal arteritis) presenting as fever of undetermined origin. (1981) (153)
- The role of parvovirus B19 in the pathogenesis of giant cell arteritis: a preliminary evaluation. (1999) (152)
- Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort. (1996) (148)
- Respiratory tract symptoms as a clue to giant cell arteritis. (1984) (142)
- Biopsy Findings in Primary Angiitis of the Central Nervous System (2009) (139)
- Giant cell arteritis: Involvement of intracranial arteries. (2006) (139)
- Clinical and Pathological Evolution of Giant Cell Arteritis: A Prospective Study of Follow-Up Temporal Artery Biopsies in 40 Treated Patients (2017) (135)
- The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain. (2000) (133)
- Relapse in a population based cohort of patients with polymyalgia rheumatica. (2005) (132)
- Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's Granulomatosis Classification Criteria Cohort. (1996) (130)
- A&bgr;-related angiitis: Comparison with CAA without inflammation and primary CNS vasculitis (2013) (119)
- Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor. (1975) (115)
- Criteria for rheumatic disease. Different types and different functions. The American College of Rheumatology Diagnostic and Therapeutic Criteria Committee. (1994) (115)
- Corticosteroid requirements in polymyalgia rheumatica. (1999) (115)
- Distal extremity swelling with pitting edema in polymyalgia rheumatica. Report on nineteen cases. (1996) (114)
- An Update of the Mayo Clinic Cohort of Patients With Adult Primary Central Nervous System Vasculitis (2015) (111)
- Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis. (2003) (111)
- Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy. (2008) (110)
- Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA. (2002) (110)
- Primary central nervous system vasculitis: pathology and mechanisms (2012) (109)
- Immunohistologic and cytochemical studies of temporal arteritis. (1983) (108)
- Serum ELAM-1 is increased in vasculitis, scleroderma, and systemic lupus erythematosus. (1993) (107)
- Adult Primary Central Nervous System Vasculitis Treatment and Course: Analysis of One Hundred Sixty‐Three Patients (2015) (107)
- Is temporal artery biopsy prudent? (1984) (106)
- Primary CNS vasculitis with spinal cord involvement (2008) (103)
- Giant cell arteritis and polymyalgia rheumatica. (1985) (100)
- The use of clinical characteristics to predict the results of temporal artery biopsy among patients with suspected giant cell arteritis. (1995) (99)
- Cervical interspinous bursitis in active polymyalgia rheumatica (2008) (98)
- Infliximab plus Prednisone or Placebo plus Prednisone for the Initial Treatment of Polymyalgia Rheumatica (2007) (97)
- Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica. (2007) (95)
- Initiation of glucocorticoid therapy: before or after temporal artery biopsy? (2004) (92)
- Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): a reversible form of encephalopathy. (1999) (91)
- Peripheral neuropathic syndromes in giant cell (temporal) arteritis (1988) (91)
- Primary central nervous system vasculitis with prominent leptomeningeal enhancement: a subset with a benign outcome. (2008) (90)
- Roentgenologic transient osteoporosis of the hip. A clinical syndrome? (1968) (88)
- Angiography-Negative Primary Central Nervous System Vasculitis: A Syndrome Involving Small Cerebral Vessels (2008) (88)
- Increase in age at onset of giant cell arteritis: a population-based study (2009) (84)
- Pleural fluid complement in systemic lupus erythematosus and rheumatoid arthritis. (1971) (84)
- The Use and Misuse of Classification and Diagnostic Criteria for Complex Diseases (1998) (84)
- Familial aggregation of polymyalgia rheumatica and giant cell arteritis. (1974) (84)
- Epidemiology of giant-cell arteritis. (2002) (83)
- Musculoskeletal manifestations in a population-based cohort of patients with giant cell arteritis. (1999) (82)
- Hypocomplementemia in rheumatoid arthritis. (1973) (80)
- Giant cell (cranial) arteritis: a clinical review. (1980) (80)
- Vasculitis: diagnosis and therapy. (1996) (77)
- Imaging Findings of Cerebral Amyloid Angiopathy, Aβ-Related Angiitis (ABRA), and Cerebral Amyloid Angiopathy–Related Inflammation (2016) (76)
- Clinical differentiation between giant cell (temporal) arteritis and Takayasu's arteritis. (1996) (73)
- Symptomatic Lower Extremity Vasculitis in Giant Cell Arteritis: A Case Series (2009) (72)
- Recognition of tissue residing antigen by T cells in vasculitic lesions of giant cell arteritis (1996) (71)
- Joint imaging in polymyalgia rheumatica. (1976) (71)
- Vasculitis. A collection of pearls and myths. (2007) (65)
- Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumatica. (1994) (64)
- Efficacy of tumor necrosis factor alpha blockade in primary central nervous system vasculitis resistant to immunosuppressive treatment. (2008) (62)
- The early history of giant cell arteritis and polymyalgia rheumatica: first descriptions to 1970. (2006) (62)
- The inflammatory infiltrate in giant cell arteritis selects against B lymphocytes. (1996) (61)
- Transient painful osteoporosis of the lower extremities. (1973) (60)
- Overtraining in neural networks that interpret clinical data. (1993) (58)
- Localized vasculitis of the gastrointestinal tract: a case series. (2010) (56)
- Primary central nervous system vasculitis presenting with intracranial hemorrhage. (2011) (56)
- Cutaneous manifestations of Takayasu's arteritis (1987) (54)
- Rapidly progressive primary central nervous system vasculitis. (2011) (53)
- Polymyalgia manifestations in different conditions mimicking polymyalgia rheumatica. (2000) (53)
- Circulating immune complexes in giant cell arteritis and polymyalgia rheumatica. (1980) (53)
- Giant cell (temporal) arteritis. (1990) (52)
- Adult primary central nervous system vasculitis: an update (2012) (51)
- Neurologic complications of giant cell (temporal) arteritis. (1994) (50)
- Extracranial angiographic findings in giant cell (temporal) arteritis. (1976) (50)
- A follow-up study of polymyalgia rheumatica: evidence of chronic axial synovitis. (1980) (48)
- Relationship of glucocorticoid dosage to serum bone Gla-protein concentration in patients with rheumatologic disorders. (1990) (48)
- Common rheumatologic diseases in elderly patients. (1995) (47)
- Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurence in a population-based study. (2001) (47)
- Decreasing prevalence of tophaceous gout. (1975) (45)
- Neurologic aspects of giant cell (temporal) arteritis. (1993) (44)
- HLA-DR locus antigens in polymyalgia rheumatica and giant cell arteritis. (1981) (44)
- Treatment of primary CNS vasculitis with rituximab: Case report (2014) (43)
- Giant-cell arteritis producing an aortic arch syndrome. (1967) (42)
- Complement in pericardial fluid of lupus erythematosus. Studies in two patients. (1974) (42)
- Increased risk of peripheral arterial disease in polymyalgia rheumatica: a population-based cohort study (2009) (41)
- Polymyalgia rheumatica with low erythrocyte sedimentation rate at diagnosis. (1999) (41)
- Imaging findings in primary central nervous system vasculitis. (2011) (41)
- Pleural fluid complement, complement conversion, and immune complexes in immunologic and nonimmunologic diseases. (1977) (40)
- Giant cell arteritis: a review. (1978) (40)
- Use of physician services in a population-based cohort of patients with polymyalgia rheumatica over the course of their disease. (2005) (40)
- Immunoglobulin E (IgE) levels in serum and synovial fluid in rheumatoid arthritis. (1974) (39)
- Application of neural networks to the classification of giant cell arteritis. (1994) (39)
- Sonography in giant-cell arteritis. (1997) (38)
- A case-control and nerve biopsy study of CREST multiple mononeuropathy (1997) (38)
- The implications of recognizing large-vessel involvement in elderly patients with giant cell arteritis. (1997) (38)
- Roentgenologic transient osteoporosis of the hip. (1968) (37)
- Diagnostic approach in a patient presenting with polymyalgia. (1999) (37)
- Ultrasound evaluation of the popliteal space. Comparison with arthrography and physical examination. (1976) (37)
- Predictors of Dissection in Aortic Aneurysms From Giant Cell Arteritis (2016) (36)
- Adult Primary Central Nervous System Vasculitis. (2019) (36)
- Synovial effusions containing cholesterol crystals report of 12 patients and review. (1979) (35)
- An attempt to predict the response to gold therapy in rheumatoid arthritis. (1984) (35)
- Vasculitis of the breast: an unusual manifestation of polyarteritis. (1974) (35)
- Direct medical costs of polymyalgia rheumatica. (2005) (34)
- Reiter's syndrome in children. A case report and review. (1971) (33)
- Comparison of three immunoassays for immune complexes in rheumatoid arthritis. (1979) (33)
- Clinical features of GCA/PMR. (2000) (32)
- Pathogenesis of giant cell arteritis. (1993) (32)
- Persistent giant cell arteritis despite corticosteroid treatment. (1994) (32)
- Synovial fluid analysis for diagnosis of amyloid arthropathy. (1987) (30)
- Lumbar interspinous bursitis in active polymyalgia rheumatica. (2013) (30)
- Synovial fluid complement determination as a diagnostic aid in inflammatory joint disease. (1974) (29)
- Superficial temporal arteriography in patients suspected of having temporal arteritis. (1972) (29)
- Polymyalgia rheumatica and giant cell arteritis. (2000) (28)
- Activation of complement components C3 and factor B in synovial fluids. (1977) (28)
- SLE nephropathy in a patient with HIV infection: case report and review of the literature. (1996) (28)
- Shoulder swelling in rheumatoid arthritis secondary to subacromial bursitis. (1978) (27)
- Giant cell arteritis involving the facial artery. (1995) (27)
- Management of primary and secondary central nervous system vasculitis (2016) (26)
- In vivo LE cell formation in synovial fluid. (1970) (26)
- Classification of vasculitis. (1993) (26)
- Factor VIII-von Willebrand factor in giant cell arteritis and polymyalgia rheumatica. (1985) (26)
- Avascular necrosis of the femoral head in a patient with gout. (1968) (24)
- Vasculitis of the gallbladder in a 70-year-old man with giant cell (temporal) arteritis. (1979) (24)
- Role of imaging in the diagnosis of large and medium-sized vessel vasculitis. (2013) (23)
- Mycophenolate mofetil in primary central nervous system vasculitis. (2015) (23)
- Vasculitis of the Gastrointestinal Tract in Chronic Periaortitis (2011) (23)
- Soluble E-selectin is increased in inflammatory synovial fluid. (1994) (23)
- Aortic Aneurysm and Dissection in Giant Cell Arteritis (1996) (22)
- Seronegative polyarthritis in giant cell arteritis. (1985) (22)
- Species differences in arsenic-mediated renal copper accumulation: a comparison between rats, mice and guinea pigs (1999) (21)
- Prothrombin, thrombin and prothrombin fragments in plasma of normal individuals and of patients with laboratory evidence of disseminated intravascular coagulation. (1979) (21)
- Synovial fluid complement: usefulness in diagnosis and classification of rheumatoid arthritis. (1974) (20)
- Aβ-related angiitis (2013) (20)
- Steroid sparing activity of tenidap in patients with polymyalgia rheumatica: a multicenter double blind randomized placebo controlled study. (1995) (20)
- Cutaneous manifestations of Takayasu's arteritis. A clinicopathologic correlation. (1987) (20)
- Cellular immunity in polymyalgia rheumatica and giant cell arteritis: lack of response to muscle or artery homogenates. (1979) (20)
- Discontinuation of therapies in polymyalgia rheumatica and giant cell arteritis. (2013) (19)
- The coexistence of rheumatoid arthritis and giant cell arteritis. (1983) (19)
- Classification/diagnostic criteria for GCA/PMR. (2000) (19)
- Alpha 1-antitrypsin in serum and synovial fluid in rheumatoid arthritis. (1974) (19)
- Primary central nervous system vasculitis associated with lymphoma (2018) (18)
- Cutaneous vasculitis and cancer: a clinical approach. (2000) (17)
- Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monoclonal rheumatoid factor. [/sup 125/I tracer technique] (1975) (17)
- Incidence of herpes zoster in patients with giant cell arteritis: a population-based cohort study. (2010) (17)
- Cancer preceding giant cell arteritis: a case-control study. (2010) (17)
- Prominent perivascular enhancement in primary central nervous system vasculitis. (2008) (16)
- Giant cell arteritis and polymyalgia rheumatica. (1992) (15)
- Long-term remission, relapses and maintenance therapy in adult primary central nervous system vasculitis: A single-center 35-year experience. (2020) (15)
- Rheumatologic interviewing and physical examination of the joints (1978) (15)
- Intermittent claudication and polymyalgia rheumatica. Association with panarteritis. (1967) (14)
- Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature. (2019) (14)
- Do we need treatment with tumour necrosis factor blockers for giant cell arteritis? (2007) (14)
- Effect of intra-articular hydrocortisone on complement in synovial fluid. (1972) (12)
- Rheumatology practice at Mayo Clinic: the first 40 years-1920 to 1960. (2010) (12)
- Bone scans in transient osteoporosis. (1971) (12)
- Dysarthria associated with giant cell arteritis. (1999) (11)
- Classification of inflammatory arthritis (1998) (11)
- Spontaneous remission of Felty's syndrome. (1975) (11)
- Giant cell (temporal) arteritis. (1997) (11)
- Polymyalgia rheumatica and giant cell arteritis. (1998) (11)
- Primary central nervous system vasculitis: Is it a single disease? (2010) (11)
- Rheumatoid granulomatous lesion simulating malignancy in the head and neck of the femur. (1965) (11)
- Treatment of Takayasu's arteritis. (1986) (10)
- Primary central nervous system vasculitis mimicking brain tumor: Comprehensive analysis of 13 cases from a single institutional cohort of 191 cases. (2019) (10)
- Is seronegative RA in the elderly the same as polymyalgia rheumatica? (1994) (10)
- Complement-fixing material in ther sera of patients with rheumatoid arthritis. (1978) (9)
- Production of Peptone Shock in Mice Following Administration of H. pertussis Vaccine (1957) (9)
- Splinter hemorrhages following arterial puncture. (1996) (9)
- Giant Cell Arteritis: Clinical Aspects (2000) (9)
- Atlas of Rheumatology (2001) (8)
- Catastrophic primary central nervous system vasculitis. (2014) (8)
- HLA antigens in patients with giant cell arteritis and polymyalgia rheumatica. (1977) (8)
- Giant cell arteritis and polymyalgia rheumatica. (1992) (8)
- Giant cell arteritis (1996) (7)
- Experimentally Induced Alterations of the Bactericidal Property of Rabbit Serum for Bacillus Subtilis (1963) (7)
- The rheumatoid factor activity of dextran eluates of erythrocytes and platelets. (1963) (6)
- The clinical significance of the RA cell. (1968) (6)
- RADIOIMMUNOASSAY WITH MONOCLONAL RHEUMATOID FACTOR (1975) (6)
- Ankylosing spondylitis and primary hyperparathyroidism. (1973) (6)
- The rheumatoid foot: diagnosis, pathomechanics and treatment. (1980) (5)
- Detection of circulating endothelial antigen. (1991) (5)
- More on polymyalgia rheumatica and giant cell arteritis. (1984) (4)
- Zinc accumulation in synovial fluid. (1972) (4)
- New directions forArthritis Care and Research (2000) (4)
- Detecting small effusions of the knee. (1966) (4)
- Sex differences in giant cell arteritis. (2003) (4)
- Polymyalgia rheumatica and giant cell arteritis in emergency department patients. (1993) (4)
- Polymyalgia rheumatica and giant-cell arteritis [6] (2002) (4)
- New Approaches for Treatment of Systemic Lupus Erythematosus (1998) (3)
- Intra-articular temperature: technique and reliability in an animal model. (1983) (3)
- Patient expectations in the clinical investigation of the first use of cortisone in rheumatoid arthritis: historical vignette (2010) (3)
- Pathogenesis of Cushing's disease. (1966) (3)
- A multicenter placebo-controlled study of methotrexate (MTX) in giant cell arteritis (GCA). (2000) (3)
- Comparison of CNS vasculitis in children and adults; is this the same disease entity (2011) (3)
- Some unusual manifestations of rheumatoid arthritis. (1967) (3)
- Giant cell arteritis in two brothers. (1986) (3)
- Pleural fluid complement. (1972) (2)
- Consumption of C3 via the classical and alternative complement pathways by sera and synovial fluids from patients with rheumatoid arthritis. (1979) (2)
- Giant cell arteritis in polymyalgia rheumatica. (1997) (2)
- Cytokines in Polymyalgia and Giant Cell Arteritis (1995) (2)
- 40 – History and Physical Examination of the Musculoskeletal System (2013) (2)
- Arthritis Care and Research on‐line (2000) (2)
- Cortisone in Popular Culture: Roueché, Ray, and Hench (2019) (2)
- Unilateral chronic relapsing primary central nervous system vasculitis. (2014) (2)
- Syndrome of inappropriate antidiuretic hormone secretion in association with temporal arteritis. (1982) (2)
- Arthritis care and research in evolution (2000) (1)
- Risk of Aspiration Pneumonia in the Elderly (2017) (1)
- OP9. TRENDS IN USE OF TEMPORAL ARTERY BIOPSY FOR THE DIAGNOSIS OF GIANT CELL ARTERITIS (GCA): EXPERIENCE IN 2,539 PATIENTS AT 3 CENTERS OVER 11 YEARS (2005) (1)
- COMMENT ON: COMPARISON OF POLYMYALGIA RHEUMATICA AND REMITTING SERONEGATIVE SYMMETRICAL SYNOVITIS WITH PITTING EDEMA SYNDROME. AUTHORS' REPLY (1996) (1)
- Vasculitides. Thomas R. Cupps, MD and Anthony S. Fauci, MD, Philadelphia, W. B. Saunders Company, 1981. 211 pages, 54 illustrations, $27 (1982) (1)
- Arthritis and Allied Conditions: A Textbook of Rheumatology (1973) (1)
- Inducible release of an endothelial cell-specific protein. (1991) (1)
- C3 Activation by the Classical and Alternative Pathways by Sera and Synovial Fluids from Patients with Rheumatoid Arthritis (R A) (1976) (1)
- Passive range of motion, not isometric exercise, amplifies acute urate synovitis. (1983) (1)
- TRENDS IN THE USE OF TEMPORAL ARTERY BIOPSY FOR THE DIAGNOSIS OF GIANT CELL ARTERITIS (GCA): EXPERIENCE IN 2539 PATIENTS AT 3 CENTERS OVER 11 YEARS: 229 (2006) (1)
- The eye and systemic disease. Edited by Frederick A. Mausolf, M.D. St. Louis, C. V. Mosby Company, 1975. 451 Pages. Price: $39.50 (1976) (1)
- lupus erythematosus: a review of the current status of discoid and systemic lupus erthematosus and their variants. Edited by Edmund L. Dubois. Second Edition, Second Printing. Los Angels, Univrsity Of Southern California Press, 1976, 798 Pages, Illustrated. (1978) (1)
- Comparison of CNS vasculitis in children and adults; is this the same disease entity (2012) (1)
- Tumor necrosis factor blocking agents in polymyalgia rheumatica and giant cell arteritis. (2008) (1)
- Case report: Association of giant cell arteritis and pituitary tumor. Report of two cases. (1979) (1)
- Methotrexate (MTX) failed to control giant cell arteritis (GCA) (2001) (1)
- Harmful effect of jogging. (1969) (1)
- New policy on disclosure of interest for American College of Rheumatology Journals. (2003) (1)
- Giant cell arteritis and primary central nervous system vasculitis as causes of headache (2020) (0)
- Giant cell arteritis: a disease of the elderly. (1983) (0)
- In Memoriam: L. Emmerson Ward, MD, 1918–2014 (2015) (0)
- Allergy and immunology . Rheumatology (1984) (0)
- Chapter 40 – History and Physical Examination of the Musculoskeletal System (2017) (0)
- Skin Manifestations in Giant Cell Arteritis (2014) (0)
- Primary CNS vasculitis: Pathophysiological diversity (2014) (0)
- Magnetic resonance imaging and polymyalgia rheumatica. (2001) (0)
- Giant cell arteritis and polymyalgia rheumatica. Author's reply (2007) (0)
- GIANT CELL ARTERITIS AND POLYMYALGIA RHEUMATICA. COMMENTARY (1992) (0)
- Treatment of rheumatoid arthritis. (1982) (0)
- Philip S. Hench’s Rheumatology Axiomatic Generalizations (2011) (0)
- OP1. HISTORY OF GIANT CELL ARTERITIS (GCA) AND POLYMYALGIA RHEUMATICA (PMR) (2005) (0)
- OP0235 Neuroimaging in Differentiating Cerebral Amyloid Angiopathy with and Without Inflammation (2015) (0)
- The pathophysiology of polymyalgia rheumatica [3] (multiple letters) (1999) (0)
- Vasculitic syndromes: Editorial overview (1990) (0)
- Diagnosis of Giant Cell Arteritis: The authors reply (1985) (0)
- Best Oral Presentations (OP01–OP12) (2012) (0)
- Outline of a treatment program for rheumatoid arthritis. (1976) (0)
- OP11. REACTIVATION OF LATENT TUBERCULOSIS INFECTION AND NEW INFECTION OF TUBERCULOSIS IN PATIENTS WITH ANTI-TUMOR NECROSIS FACTOR THERAPY FOR TUBERCULOSIS-ENDEMIC AREA (2012) (0)
- The vasculitides. (1983) (0)
- POL YMY ALGIA RHEUMATICA AND GIANT CELL ARTERITIS .7261 (1978) (0)
- Concise report Incidence of herpes zoster in patients with giant cell arteritis: a population-based cohort study RHEUMATOLOGY (2010) (0)
- FRI0356 Primary Central Nervous System Vasculitis Associated with Lymphomas (2016) (0)
- 162 a ,-Antitrypsin in serum and synovial fluid in rheumatoid arthritis (0)
- New series of articles in Arthritis Care and Research (2001) (0)
- Exploring Gene Expression Profiles in Primary Central Nervous System Vasculitis (2022) (0)
- Overtraining in NeuralNetworksThat InterpretClinicalData (1993) (0)
- Aortic dissection in giant cell arteritis: A population-based study of predictors (2013) (0)
- New policy on disclosure of interest for American College of Rheumatology journals. (2003) (0)
- Bulge sign. (1972) (0)
- Pericarditis and rheumatic disease (1986) (0)
- Calculating Likelihood Ratios in Patients With Giant Cell Arteritis: In Response (2004) (0)
- Complement in Pericardial Fluid of Lupus Erythematosus (2020) (0)
- Biopsy of the Temporal Artery: The authors reply (1985) (0)
- Arteritis and connective tissue diseases involving the arteries (1992) (0)
- Reply (2008) (0)
- Skin Manifestations in Microscopic Polyangiitis (2014) (0)
- Handling of Fe3+ and Ni2+ nitriloacetates by two different strains of madin-darby canine kidney cells exhibiting transferrin-independent iron uptake (2001) (0)
- Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases. (2023) (0)
- Agglutinins eluted from erythrocytes of rheumatoid patients. (1966) (0)
- Polymyalgia rheumatica with low erythrocyte sedimentation rate [3] (multiple letters) (2000) (0)
- andinChronic Glucocorticoid Excess (1980) (0)
- The systemic manifestations of temporal arteritis. louis a. healey, md, kenneth r. wilske, md. new york, grune and stratton, inc., 1979. 140 pages. price: $12.50 (1980) (0)
- Giant Cell Arteritis and Polymyalgia Rheumatica–Reply–I (2007) (0)
- Transient Regional Osteoporosis (2020) (0)
- FRI0479 Primary central nervous system vasculitis with tumor-like presentation (2018) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Gene G. Hunder?
Gene G. Hunder is affiliated with the following schools:
